LS
IONS icon

Lupo Securities’s Ionis Pharmaceuticals IONS Stock Holding History

Lupo Securities’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$117K Buy
2,900
+1,900
+190% +$98.3K 0.88% 18
2015
Q2 		$58K Buy
+1,000
New +$63.6K 0.23% 29

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Lupo Securities's IONS Position: Q3 2015 in Review

Lupo Securities increased its Ionis Pharmaceuticals (IONS) stake by 190% in Q3 2015, buying an estimated $98.3K and bringing the position to 2,900 shares worth $117K. The position accounts for 0.88% of the portfolio, ranked #18.

Lupo Securities first reported a position in IONS in Q2 2015 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold IONS as of Q3 2015.

  • Lupo Securities held 2,900 shares of Ionis Pharmaceuticals worth $117K as of Q3 2015.
  • Lupo Securities bought 1,900 Ionis Pharmaceuticals shares in Q3 2015, an estimated $98.3K.
  • Ionis Pharmaceuticals made up 0.88% of Lupo Securities's portfolio in Q3 2015, its #18 holding.
  • Lupo Securities first reported a position in Ionis Pharmaceuticals in Q2 2015 and has held it in 2 quarters since.
  • 314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2015.

Based on Lupo Securities's 13F filing for Q3 2015, filed 13 Nov 2015.